Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C-Reference-Cited by-同舟云学术

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C

Published:2013-01-31 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Koretz Ronald L¹,Pleguezuelo Maria²,Arvaniti Vasiliki³,Barrera Baena Pilar⁴,Ciria Ruben⁵,Gurusamy Kurinchi Selvan⁶,Davidson Brian R⁶,Burroughs Andrew K⁷

Affiliation:

1. 16847 Colven Road Granada Hills CA USA CA 91344

2. Reina Sofia University Hospital; Department of Hepatology; Menendez Pidal s/n Cordoba Spain 14004

3. Royal Free Hampstead NHS Foundation Trust; Department of Liver Transplantation and Hepatobiliary Medicine; Pond Street Hampstead London UK NW3 2QG

4. Reina Sofia University Hospital; Department of Gastroenterology and Hepatology; Cordoba Spain

5. Reina Sofia University Hospital; Department of Surgery; Cordoba Spain

6. Royal Free Campus, UCL Medical School; Department of Surgery; Royal Free Hospital, Pond Street London UK NW3 2QG

7. Royal Free Hampstead NHS Foundation Trust; Sheila Sherlock Liver Centre; Pond Street Hampstead London UK NW3 2QG

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD003617.pub2/fullpdf

Reference232 articles.

1. Maintenance therapy with gradual reduction of the interferon dose over one year improves histological response in patients with chronic hepatitis C with biochemical response: results of a randomized trial;Alric;Journal of Hepatology,2001

2. Re-treatment of interferon-resistant patients with chronic hepatitis C with interferon-alpha;Bresci;Journal of Viral Hepatitis,1995

3. Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C;Bruix;Gastroenterology,2011

4. Final results of the EPIC3 cirrhosis maintenance trial: pegintron maintenance therapy in cirrhotic (METAVIR F4) HCV patients, who failed to respond to interferon/ribavirin (IR) therapy;Bruix;Gastroenterology,2009

5. Impact of peginterferon maintenance therapy on biomarkers (Fibrotest [FT]-Acitest [AT]) in cirrhotic (METAVIR F4) HCV prior non-responders. Results from the EPIC3 cirrhosis maintenance trial;Poynard;Hepatology,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27

2. Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapy;Medicine;2019-05

3. Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment;BMJ Evidence-Based Medicine;2018-08-31

4. Who is wrong? Responses to Kwo et al.;American Journal of Gastroenterology;2018-05

5. The Cochrane Review Conclusion for Hepatitis C DAA Therapies is Wrong;American Journal of Gastroenterology;2018-01